My Lymphoma biopsy was inconclusive — what happens next
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
What an Inconclusive Lymphoma Biopsy Means
An inconclusive biopsy result is frustrating, but it's not uncommon in lymphoma diagnosis. Let me explain what this means and what typically happens next.
Why Biopsies Can Be Inconclusive
According to the NCCN Guidelines for Patients: Marginal Zone Lymphomas, a lymph node biopsy is a critical test that can be performed in several ways:
- Fine-needle aspiration (FNA) - uses a thin needle to remove a small sample
- Core biopsy (CB) - uses a slightly larger needle
- Excisional biopsy - removes the entire lymph node or tumor through a small surgical cut
An inconclusive result typically means one of these situations:
- Not enough tissue was collected to make a definitive diagnosis
- The sample quality was poor (damaged during collection or processing)
- The findings are ambiguous and don't clearly fit one lymphoma type
- Additional testing is needed to clarify what the cells show
What Happens Next: Your Care Team's Approach
Your oncology team will likely recommend one or more of these steps:
1. Repeat Biopsy A second biopsy is often the next step. Your doctor may:
- Use a different biopsy technique (for example, if a fine-needle aspiration was done first, an excisional biopsy might be recommended)
- Sample a different lymph node or affected area
- Ensure adequate tissue is collected for complete testing
2. Additional Testing on Existing Samples If tissue was collected, your pathologist may perform:
- Immunophenotyping - uses special antibodies to identify specific markers on lymphoma cells (like CD10, BCL2, CD20, and others) that help classify the lymphoma type
- Flow cytometry - a laboratory method that uses light-sensitive dyes to identify and count specific cell types
- Genetic/molecular testing - looks for specific mutations or chromosomal changes that can affect diagnosis and treatment options
According to NCCN guidelines, mutation testing is important because certain genetic changes can be targeted with specific therapies and may affect your prognosis.
3. Imaging Studies Your doctor may order imaging tests to better understand your situation:
- CT scan - uses X-rays and computer technology to create detailed pictures
- PET scan - uses a radioactive tracer to show where cancer cells are active
- PET/CT scan - combines both for comprehensive imaging
These help your care team see the full picture of your lymphoma.
Questions to Ask Your Healthcare Team
Since your biopsy was inconclusive, here are important questions to discuss:
- Why was the biopsy inconclusive? (Not enough tissue? Quality issues? Ambiguous findings?)
- Do you recommend a repeat biopsy, and if so, which type?
- What additional testing can be done on the tissue that was collected?
- What imaging studies do you recommend, and when?
- How long will it take to get results from any repeat testing?
- In the meantime, do I need any treatment, or do we wait for clearer results?
- Are there any clinical trials that might be appropriate while we work toward a diagnosis?
Important Resources
The Lymphoma Research Foundation (lymphoma.org) and NCI's Cancer Information Service (cancer.gov) offer patient-friendly information about lymphoma diagnosis and can help you find clinical trials if your doctor recommends exploring that option.
Moving Forward
An inconclusive biopsy is a setback, but it's a solvable problem. Your care team has multiple tools to get the clarity needed for an accurate diagnosis. The key is staying in close communication with your oncologist about the next steps and timeline.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Lymphoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: